मूलभूत आँकड़े
| CIK | 1726445 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Seer, Inc.
SEC Filings (Chronological Order)
यह पृष्ठ SEC फाइलिंग की एक पूरी, कालानुक्रमिक सूची प्रदान करता है, ओनरशिप फाइलिंग को छोड़कर, जो हम अन्यत्र प्रदान करते हैं।
| September 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 2, 2025 Seer, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer incorpor |
|
| September 5, 2025 |
Seer Appoints Isaac Ro to its Board of Directors Seer Appoints Isaac Ro to its Board of Directors REDWOOD CITY, Calif., Sept. 2, 2025 - Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced it has appointed Isaac Ro to serve on its Board of Directors. “We are excited to welcome Isaac to our board,” said Omid Farokhzad, Chair and CEO of Seer. “Isaac brings a rare combination of financial |
|
| August 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number |
|
| August 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 6, 2025 Seer, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer incorporati |
|
| August 6, 2025 |
Seer Reports Second Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook Revenue grew 32% year-over-year, driven by increased product sales and service revenue Launched new high-throughput Proteograph® ONE assay and SP200 automation instrument REDWOOD CITY, Calif. |
|
| July 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 7, 2025 Seer, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer incorporation |
|
| May 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State |
|
| May 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy State |
|
| May 13, 2025 |
Seer Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook Revenue grew 37%, driven by increased product sales and service revenue REDWOOD CITY, Calif. |
|
| May 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe |
|
| May 13, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 13, 2025 Seer, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer incorporation |
|
| April 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark one) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0 |
|
| March 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark one) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-39747 SEER, INC. |
|
| March 3, 2025 |
Outside Director Compensation Policy (as amended on February 26, 2025). Exhibit 10.12 SEER, INC. OUTSIDE DIRECTOR COMPENSATION POLICY (as most recently amended and restated effective as of February 26, 2025 (the “Restatement Date”)) Seer, Inc. (the “Company”) believes that the granting of equity and cash compensation to members of the Company’s Board of Directors (the “Board,” and members of the Board, “Directors”) represents an effective tool to attract, retain and r |
|
| March 3, 2025 |
2017 Stock Incentive Plan and related form agreements. Exhibit 10.3 SEER, INC. 2017 Stock Incentive Plan (As Amended and Restated November 18, 2020) 1. Purpose. The purpose of this plan (the “Plan”) is to secure for Seer, Inc., a Delaware corporation, or any successor thereto (the “Company”) and its shareholders the benefits arising from capital stock ownership by employees, officers and directors of, and consultants or advisors to, the Company and it |
|
| March 3, 2025 |
Exhibit 4.2 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 Seer, Inc. (the “Company”) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: our Class A common stock, par value $0.00001 per share. As used in this summary, the terms “Seer,” “the Company,” “we,” “our” and “us” re |
|
| March 3, 2025 |
List of Subsidiaries of the Registrant. Exhibit 21.1 List of Subsidiaries: 1. Seer Bio UK Limited (United Kingdom) 2. Seer Bio GmbH (Germany) |
|
| February 27, 2025 |
Seer Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Outlook Validated technology with exceptional growth of customer publications and enhanced access to the Proteograph Product Suite with growing demand for Seer Technology Access Center (STAC) REDWOOD CITY, Calif. |
|
| February 27, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2025 Seer, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer incorpor |
|
| February 12, 2025 |
Exhibit 99.1 Joint Filing Agreement The undersigned hereby agree that the Statement on Schedule 13G dated February 12, 2025, with respect to the Class A common stock, $0.00001 par value per share, of Seer, Inc., and any amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k |
|
| November 6, 2024 |
Seer Reports Third Quarter 2024 Financial Results Growing enthusiasm for Proteograph Product Suite with multiple larger orders from government agencies and continued strong interest in STAC REDWOOD CITY, Calif. |
|
| November 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file n |
|
| November 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2024 Seer, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer incorpora |
|
| October 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 4, 2024 Seer, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer incorporat |
|
| October 7, 2024 |
Seer Appoints Nicolas Roelofs to its Board of Directors Seer Appoints Nicolas Roelofs to its Board of Directors REDWOOD CITY, Calif. Aug. 14, 2024 – Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced it has appointed Dr. Nicolas Roelofs to serve on its Board of Directors. “Nick is a fantastic addition to our board, bringing over 35 years of broad operational and advisory |
|
| August 16, 2024 |
Seer Appoints Nicolas Roelofs to its Board of Directors Seer Appoints Nicolas Roelofs to its Board of Directors REDWOOD CITY, Calif. Aug. 14, 2024 – Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced it has appointed Dr. Nicolas Roelofs to serve on its Board of Directors. “Nick is a fantastic addition to our board, bringing over 35 years of broad operational and advisory |
|
| August 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 13, 2024 Seer, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer incorporat |
|
| August 8, 2024 |
Seer Reports Second Quarter 2024 Financial Results Launched STAC in Europe and additional customer papers published in leading journals REDWOOD CITY, Calif. |
|
| August 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-39747 SEER, I |
|
| August 8, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2024 Seer, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer incorporati |
|
| August 2, 2024 |
SEER / Seer, Inc. / Invus Global Management, LLC - SC 13G/A Passive Investment SC 13G/A 1 d799830dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934* (Amendment No. 3) SEER, INC. (Name of Issuer) Class A Common Stock, par value $0.00001 per share (Title of Class of Securities) 81578P106 (CUSIP Number) July 25, 2024 (Date of Event Which Requires Filing of this Statement) Check the |
|
| August 2, 2024 |
EX-99.1 2 d799830dex991.htm EX-1 EXHIBIT 1 JOINT FILING AGREEMENT The undersigned agree that the statement on Schedule 13G with respect to the securities of Seer, Inc. is, and any amendments thereto signed by each or any of the undersigned shall be, filed on behalf of each of such person pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, a |
|
| July 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 16, 2024 Seer, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer incorporatio |
|
| July 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 8, 2024 Seer, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer incorporation |
|
| June 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 12, 2024 Seer, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer incorporatio |
|
| May 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-39747 SEER, |
|
| May 8, 2024 |
Seer Reports First Quarter 2024 Financial Results Demonstrated the power of the Proteograph Product Suite with a growing number of customer presentations and publications REDWOOD CITY, Calif. |
|
| May 8, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2024 Seer, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer incorporation) |
|
| May 8, 2024 |
Outside Director Compensation Policy (as amended on February 28, 2024). Exhibit 10.1 SEER, INC. OUTSIDE DIRECTOR COMPENSATION POLICY (as most recently amended and restated effective as of February 28, 2024 (the “Restatement Date”)) Seer, Inc. (the “Company”) believes that the granting of equity and cash compensation to members of the Company’s Board of Directors (the “Board,” and members of the Board, “Directors”) represents an effective tool to attract, retain and re |
|
| April 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State |
|
| April 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy State |
|
| March 6, 2024 |
Exhibit 107 CALCULATION OF REGISTRATION FEE TABLE Form S-8 (Form Type) Seer, Inc. (Exact name of Registrant as Specified in its Charter) Table 1 – Newly Registered Securities Security Type Securities Class Type Fee Calculation Rule Amount to be Registered(1) Proposed Maximum Offering Price Per Share Proposed Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Class A common |
|
| March 6, 2024 |
As filed with the Securities and Exchange Commission on March 6, 2024 As filed with the Securities and Exchange Commission on March 6, 2024 Registration No. |
|
| March 4, 2024 |
Exhibit 97.1 SEER, INC. COMPENSATION RECOVERY POLICY As adopted on November 14, 2023 Seer, Inc. (the “Company”) is committed to strong corporate governance. As part of this commitment, the Talent and Compensation Committee (the “Committee”) of the Company’s Board of Directors (the “Board”) has adopted this clawback policy called the Compensation Recovery Policy (the “Policy”). The Policy is intend |
|
| March 4, 2024 |
Exhibit 4.2 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 Seer, Inc. (the “Company”) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: our Class A common stock, par value $0.00001 per share. As used in this summary, the terms “Seer,” “the Company,” “we,” “our” and “us” re |
|
| March 4, 2024 |
Offer Letter between the Registrant and Elona Kogan, dated November 4, 2020. Exhibit 10.14 November 4, 2020 Elona Kogan Re: Offer of Employment Dear Elona: I am pleased to offer you a position with Seer, Inc. (the “Company”) in accordance with the terms of this employment letter agreement (the “Agreement”). 1. Title; Position; Location. You will serve as the Company’s General Counsel and Corporate Secretary. You will report to the Company’s Chief Executive Officer (the “CE |
|
| March 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark one) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-39747 SEER, INC. |
|
| March 4, 2024 |
Exhibit 19.1 SEER, INC. INSIDER TRADING POLICY and Guidelines with Respect to Certain Transactions in Securities (Adopted and approved on November 18, 2020 and effective as of the Company’s initial public offering, as amended on April 18, 2023) TABLE OF CONTENTS Page INTRODUCTION 1 Legal prohibitions on insider trading 1 Detection and prosecution of insider trading 1 Penalties for violation of ins |
|
| February 29, 2024 |
Exhibit 99.1 Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook Enhanced access to the Proteograph Product Suite and demonstrated its power with new customer data REDWOOD CITY, Calif. February 29, 2024 – Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today reported financial resu |
|
| February 29, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 29, 2024 Seer, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer incorpor |
|
| February 14, 2024 |
SEER / Seer, Inc. / Farokhzad Omid - SC 13G/A Passive Investment SC 13G/A 1 tm246324d1sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 3)* SEER, INC. (Name of Issuer) Class A Common Stock, $0.00001 par value per share (Title of Class of Securities) 81578P 106 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Che |
|
| February 13, 2024 |
SEER / Seer, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv01891-seerincclassa.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 2)* Name of issuer: Seer, Inc. Class A Title of Class of Securities: Common Stock CUSIP Number: 81578P106 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate t |
|
| February 13, 2024 |
SEER / Seer, Inc. / SOFTBANK GROUP CORP Passive Investment United States Securities and Exchange Commission Washington, D.C. 20549 Schedule 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to § 240.13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 2)* Seer, Inc. (Name of Issuer) Class A Common Stock (Title of Class of Securities) 81578P106 (CUSIP Nu |
|
| February 13, 2024 |
EX-99 2 ex99.htm Exhibit 99 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that they are jointly filing this statement on Schedule 13G. Each of them is responsible for the timely filing of such statement and any amendments thereto, and for the completeness and accuracy of the information con |
|
| February 9, 2024 |
SEER / Seer, Inc. / Capital World Investors - SEC SCHEDULE 13G Passive Investment SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Seer, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 81578P106 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designat |
|
| January 3, 2024 |
SEER / Seer, Inc. / Schindel Yair Chaim - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 Seer, Inc. (Name of Issuer) Class A Common Stock, Par Value $0.00001 per Share (Title of Class of Securities) 81578P106 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to wh |
|
| December 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 21, 2023 Seer, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer incorpor |
|
| November 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 14, 2023 Seer, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer incorpor |
|
| November 7, 2023 |
Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2023 Seer, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer incorpora |
|
| November 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-39747 SE |
|
| November 7, 2023 |
Seer Reports Third Quarter 2023 Financial Results Expanded access to the Proteograph™ Product Suite through the Seer Technology Access Center, new distributors and a new Center of Excellence REDWOOD CITY, Calif. |
|
| November 7, 2023 |
Key Executive Change in Control and Severance Plan, and form of Participation Agreement thereunder. SEER, INC. KEY EXECUTIVE CHANGE IN CONTROL AND SEVERANCE PLAN As Amended and Restated 1.Introduction. This Seer, Inc. Key Executive Change in Control and Severance Plan (as may be amended from time to time, this “Plan”) has been adopted by Seer, Inc. (the “Company”), effective as of the day immediately prior to the Registration Date (the “Effective Date”), in order to provide specified severance p |
|
| August 8, 2023 |
Seer Reports Second Quarter 2023 Financial Results Launched Proteograph XT Assay Kit, enabling rapid proteomics and large-scale studies REDWOOD CITY, Calif. |
|
| August 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-39747 SEER, I |
|
| August 8, 2023 |
Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2023 Seer, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer incorporati |
|
| July 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 18, 2023 Seer, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer incorporatio |
|
| June 16, 2023 |
Amendment to the Amended and Restatement Certificate of Incorporation of the Company. CERTIFICATE OF AMENDMENT OF THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF SEER, INC. |
|
| June 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 15, 2023 Seer, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer incorporatio |
|
| June 16, 2023 |
Amended and Restated Bylaws of the Registrant. AMENDED AND RESTATED BYLAWS OF SEER, INC. (initially adopted on December 8, 2020) (as amended and restated on June 14, 2023) TABLE OF CONTENTS Page ARTICLE I - CORPORATE OFFICES 1 1.1 REGISTERED OFFICE 1 1.2 OTHER OFFICES 1 ARTICLE II - MEETINGS OF STOCKHOLDERS 1 2.1 PLACE OF MEETINGS 1 2.2 ANNUAL MEETING 1 2.3 SPECIAL MEETING 1 2.4 ADVANCE NOTICE PROCEDURES 2 2.5 NOTICE OF STOCKHOLDERS’ MEETINGS |
|
| May 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2023 Seer, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer incorporation) |
|
| May 9, 2023 |
Seer Reports First Quarter 2023 Financial Results Grew revenue 22% year-over-year with continued growth in installed base and an increasing number of customer presentations and publications REDWOOD CITY, Calif. |
|
| May 9, 2023 |
Outside Director Compensation Policy (as amended on February 16, 2023) OUTSIDE DIRECTOR COMPENSATION POLICY (as most recently amended and restated effective as of February 16, 2023 (the “Restatement Date”)) Seer, Inc. |
|
| May 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-39747 SEER, |
|
| April 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy State |
|
| April 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy State |
|
| April 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: x Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy State |
|
| March 8, 2023 |
As filed with the Securities and Exchange Commission on March 8, 2023 As filed with the Securities and Exchange Commission on March 8, 2023 Registration No. |
|
| March 8, 2023 |
Exhibit 107 CALCULATION OF REGISTRATION FEE TABLE Form S-8 (Form Type) Seer, Inc. (Exact name of Registrant as Specified in its Charter) Table 1 – Newly Registered Securities Security Type Securities Class Type Fee Calculation Rule Amount to be Registered(1) Proposed Maximum Offering Price Per Share Proposed Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Class A common |
|
| March 8, 2023 |
Amended and Restated 2020 Employee Stock Purchase Plan and related form agreements. Exhibit 4.3 SEER, INC. 2020 EMPLOYEE STOCK PURCHASE PLAN (As most recently amended and restated February 15, 2023) 1.Purpose. The purpose of the Plan is to provide employees of the Company and its Designated Companies with an opportunity to purchase Common Stock through accumulated Contributions. The Company intends for the Plan to have two components: a component that is intended to qualify as an |
|
| March 6, 2023 |
List of Subsidiaries of the Registrant. EX-21.1 List of Subsidiaries: 1.Seer Securities Corporation (Massachusetts) 2.Seer Bio UK Limited (United Kingdom) |
|
| March 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark one) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-39747 SEER, INC. |
|
| March 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 2, 2023 Seer, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer incorporatio |
|
| March 2, 2023 |
Seer Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Full Year 2023 Outlook Grew revenue 134% and increased instruments shipped 129% year over year REDWOOD CITY, Calif. |
|
| February 14, 2023 |
SEER / Seer, Inc. Class A / Farokhzad Omid - SC 13G/A Passive Investment SC 13G/A 1 tm236774d1sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 2)* SEER, INC. (Name of Issuer) Class A Common Stock, $0.00001 par value per share (Title of Class of Securities) 81578P 106 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Che |
|
| February 13, 2023 |
SEER / Seer, Inc. Class A / Capital World Investors - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Seer, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 81578P106 (CUSIP Number) December 30, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is f |
|
| February 9, 2023 |
SEER / Seer, Inc. Class A / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1)* Name of issuer: Seer Inc. Class A Title of Class of Securities: Common Stock CUSIP Number: 81578P106 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ R |
|
| January 9, 2023 |
SEER / Seer, Inc. Class A / Schindel Yair Chaim - SC 13G/A Passive Investment SC 13G/A 1 zk2328985.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 Seer, Inc. (Name of Issuer) Class A Common Stock, Par Value $0.001 per Share (Title of Class of Securities) 81578P106 (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate box to d |
|
| November 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-39747 SE |
|
| November 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2022 Seer, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer incorpora |
|
| November 8, 2022 |
Seer Reports Third Quarter 2022 Financial Results Proteograph utility is demonstrated as market interest continues to build with multiple studies underway REDWOOD CITY, Calif. |
|
| August 26, 2022 |
Consultant Agreement between the Company and Omead Ostadan dated August 25, 2022. SEER, INC. CONSULTANT AGREEMENT This Consultant Agreement (?Agreement?) is entered into as of September 30, 2022 (the ?Effective Date?) between Seer, Inc., a Delaware corporation with its principal place of business at 3800 Bridge Parkway, Suite 102, Redwood City, CA 94065 (?Company?) and Omead Ostadan, an individual (?Consultant?). Consultant has unique skills and knowledge pertinent to the Compa |
|
| August 26, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 25, 2022 Seer, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer incorporat |
|
| August 15, 2022 |
SEER / Seer, Inc. Class A / MAVERICK CAPITAL MANAGEMENT LLC - SC 13D/A Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 3)* Seer, Inc. (Name of Issuer) Class A Common Stock, $0.00001 par value per share (Title of Class of Securities) 81578P 106 (CUSIP Number) Mark Gurevich Maverick Capital, Ltd. 1900 N. Pearl Street, 20th Floor Dallas, TX 75201 (214) 880-4000 (Name, Address and Telephone |
|
| August 9, 2022 |
Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2022 Seer, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer incorporati |
|
| August 9, 2022 |
Seer Reports Second Quarter 2022 Financial Results Company launches novel proteogenomics workflow with the Proteograph TM Analysis Suite 2. |
|
| August 9, 2022 |
Outside Director Compensation Policy (as amended on June 15, 2022) SEER, INC. OUTSIDE DIRECTOR COMPENSATION POLICY (as amended and restated effective as of June 15, 2022 (the ?Restatement Date?)) Seer, Inc. (the ?Company?) believes that the granting of equity and cash compensation to members of the Company?s Board of Directors (the ?Board,? and members of the Board, ?Directors?) represents an effective tool to attract, retain and reward Directors who are not empl |
|
| August 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-39747 SEER, I |
|
| June 17, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 15, 2022 Seer, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer incorporatio |
|
| May 6, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-39747 SEER, |
|
| May 6, 2022 |
2020 Employee Stock Purchase Plan Ex 10.1 SEER, INC. 2020 EMPLOYEE STOCK PURCHASE PLAN (As most recently amended and restated April 20, 2022) 1.Purpose. The purpose of the Plan is to provide employees of the Company and its Designated Companies with an opportunity to purchase Common Stock through accumulated Contributions. The Company intends for the Plan to have two components: a component that is intended to qualify as an ?emplo |
|
| May 4, 2022 |
Ex 99.1 Seer Reports First Quarter 2022 Financial Results Demonstrated solid commercial traction with continued robust interest in the Proteograph Product Suite REDWOOD CITY, Calif. May 4, 2022 ? Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results for the first quarter ended March 31, 2022. ?We had a strong s |
|
| May 4, 2022 |
Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2022 Seer, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer incorporation) |
|
| April 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy State |
|
| April 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy State |
|
| April 21, 2022 |
April 21, 2022 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Mail Stop 3030 Washington, D. |
|
| April 8, 2022 |
SEER / Seer, Inc. Class A / MAVERICK CAPITAL MANAGEMENT LLC - SC 13D/A Activist Investment SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* Seer, Inc. (Name of Issuer) Class A Common Stock, $0.00001 par value per share (Title of Class of Securities) 81578P 106 (CUSIP Number) Mark Gurevich Maverick Capital, Ltd. 1900 N. Pearl Street, 20th Floor Dallas, TX 75201 (214) 880-4000 (Name, Address and |
|
| March 18, 2022 |
Confirmatory Offer Letter between the Registrant and Scott Thomas, dated March 2, 2022. Ex 10.1 March 2, 2022 Scott Thomas Re: Offer of Employment Dear Scott, I am pleased to offer you a position with Seer, Inc. (the ?Company?) in accordance with the terms of this employment letter agreement (the ?Agreement?). 1.Title; Position; Location. You will serve as the Company?s Chief Commercial Officer (CCO). You will report to the Company?s Chief Executive Officer (the ?CEO?) and will perfo |
|
| March 18, 2022 |
Ex 99.1 Seer Announces Appointment of Scott D. Thomas as Chief Commercial Officer Seasoned life sciences executive adds extensive global sales expertise to drive commercial efforts REDWOOD CITY, Calif., March 16, 2022 ? Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, announced today the appointment of Scott D. Thomas as Chief Commercial |
|
| March 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 16, 2022 Seer, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer incorporati |
|
| March 3, 2022 |
Exhibit 107 CALCULATION OF REGISTRATION FEE TABLE Form S-8 (Form Type) Seer, Inc. (Exact name of Registrant as Specified in its Charter) Table 1 ? Newly Registered Securities Security Type Securities Class Type Fee Calculation Rule Amount to be Registered(1) Proposed Maximum Offering Price Per Share Proposed Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Class A common |
|
| March 3, 2022 |
As filed with the Securities and Exchange Commission on March 3, 2022 As filed with the Securities and Exchange Commission on March 3, 2022 Registration No. |
|
| March 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark one) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-39747 SEER, INC. |
|
| February 28, 2022 |
Ex 99.1 Seer Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Full Year 2022 Outlook Demonstrated tangible market progress and shipped 17 instruments through year end 2021 REDWOOD CITY, Calif. Feb 28, 2022 ? Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results for the fourth quarter and |
|
| February 28, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2022 Seer, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer incorpor |
|
| February 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 18, 2022 Seer, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer incorpor |
|
| February 18, 2022 |
Ex 10.1 February 18, 2022 Omead Ostadan Via email Re: Confirmatory Employment Letter, as Amended Dear Omead: This confirmatory employment letter agreement (the ?Agreement?) is entered into between Omead Ostadan (?you?) and Seer, Inc. (the ?Company? or ?we?), effective as of February 28, 2022 (the ?Effective Date?), to reflect the amended terms and conditions of your employment with the Company as |
|
| February 14, 2022 |
SEER / Seer, Inc. Class A / Farokhzad Omid - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* SEER, INC. (Name of Issuer) Class A Common Stock, $0.00001 par value per share (Title of Class of Securities) 81578P106 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the ru |
|
| February 14, 2022 |
Exhibit 99 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that they are jointly filing this statement on Schedule 13G. |
|
| February 14, 2022 |
SEER / Seer, Inc. Class A / SB Global Advisors Ltd - SC 13G/A Passive Investment United States Securities and Exchange Commission Washington, D.C. 20549 Schedule 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to ? 240.13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to ? 240.13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* Seer, Inc. (Name of Issuer) Class A Common Stock (Title of Class of Securities) 81578P106 (CUSIP Nu |
|
| February 11, 2022 |
SEER / Seer, Inc. Class A / Artal International S.C.A. - SC 13G/A Passive Investment SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934* (Amendment No. 2) SEER, INC. (Name of Issuer) Class A Common Stock, par value $0.00001 per share (Title of Class of Securities) 81578P106 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designa |
|
| February 10, 2022 |
SEER / Seer, Inc. Class A / VANGUARD GROUP INC - SCHEDULE 13G Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 Name of issuer: Seer Inc. Class A Title of Class of Securities: Common Stock CUSIP Number: 81578P106 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13d-1(b) ☐ Rule |
|
| January 24, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 18, 2022 Seer, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer incorpora |
|
| January 24, 2022 |
SEER / Seer, Inc. Class A / Schindel Yair Chaim - SC 13G/A Passive Investment SC 13G/A 1 zk2227091.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 Seer, Inc. (Name of Issuer) Class A Common Stock, Par Value $0.001 per Share (Title of Class of Securities) 81578P106 (CUSIP Number) December 31, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to d |
|
| November 29, 2021 |
Seer Appoints Meeta Gulyani to its Board of Directors Ex 99.1 Seer Appoints Meeta Gulyani to its Board of Directors Redwood City, Calif., Nov. 29, 2021 ? Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it has appointed Meeta Gulyani to serve on its Board of Directors. Ms. Gulyani is currently Executive Vice President, Head of Strategy, Business Development and Transformatio |
|
| November 29, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 29, 2021 Seer, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer incorpor |
|
| November 17, 2021 |
SEER / Seer, Inc. Class A / MAVERICK CAPITAL MANAGEMENT LLC - SC 13D/A Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Seer, Inc. (Name of Issuer) Class A Common Stock, $0.00001 par value per share (Title of Class of Securities) 81578P 106 (CUSIP Number) Mark Gurevich Maverick Capital, Ltd. 1900 N. Pearl Street, 20th Floor Dallas, TX 75201 (214) 880-4000 (Name, Address and Telephone |
|
| November 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-39747 SE |
|
| November 9, 2021 |
Seer Reports Third Quarter 2021 Financial Results Customers demonstrate novel methods using the Proteograph Product Suite and continued commercial momentum ahead of Broad Release in early 2022 REDWOOD CITY, Calif. |
|
| November 9, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2021 Seer, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer incorpora |
|
| November 8, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2021 Seer, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer incorpora |
|
| November 8, 2021 |
Seer Appoints Rachel Haurwitz, Ph.D., to its Board of Directors Seer Appoints Rachel Haurwitz, Ph.D., to its Board of Directors Redwood City, CA, November 8, 2021 ? Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it has appointed Rachel Haurwitz, Ph.D. to serve on its Board of Directors, effective November 8, 2021. Dr. Haurwitz is currently CEO of Caribou Biosciences, Inc. a clinical |
|
| October 13, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 7, 2021 SEER, INC. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of incorporation) (Commission File No.) (I |
|
| October 13, 2021 |
Leave of Absence Agreement between Omead Ostadan and the Company effective October 7, 2021. Ex. 10.1 LEAVE OF ABSENCE AGREEMENT This Leave of Absence Agreement (the ?Agreement?) is made by and between Omead Ostadan (?Employee?) and Seer, Inc. (the ?Company?) (collectively referred to as the ?Parties? or individually referred to as a ?Party?), effective as of October 7, 2021 (the ?Effective Date?). RECITALS WHEREAS, Employee is employed by the Company pursuant to the Confirmatory Employme |
|
| August 12, 2021 |
Outside Director Compensation Policy Ex. 10.1 SEER, INC. OUTSIDE DIRECTOR COMPENSATION POLICY (as amended and restated on June 16, 2021 (the ?Restatement Date?)) Seer, Inc. (the ?Company?) believes that the granting of equity and cash compensation to members of the Company?s Board of Directors (the ?Board,? and members of the Board, ?Directors?) represents an effective tool to attract, retain and reward Directors who are not employee |
|
| August 12, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2021 Seer, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer incorporat |
|
| August 12, 2021 |
2020 Employee Stock Purchase Plan Ex. 10.2 SEER, INC. 2020 EMPLOYEE STOCK PURCHASE PLAN 1.Purpose. The purpose of the Plan is to provide employees of the Company and its Designated Companies with an opportunity to purchase Common Stock through accumulated Contributions. The Company intends for the Plan to have two components: a component that is intended to qualify as an ?employee stock purchase plan? under Code Section 423 (the ? |
|
| August 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-39747 SEER, I |
|
| June 23, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 16, 2021 SEER, INC. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of incorporation) (Commission File No.) (IRS |
|
| May 11, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-39747 SEER, |
|
| May 10, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2021 Seer, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer incorporation |
|
| April 28, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy State |
|
| April 28, 2021 |
DEFA14A 1 a2020proxynotice.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rul |
|
| March 29, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 29, 2021 Seer, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer incorporati |
|
| March 29, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark one) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number SEER, INC. (Exact nam |
|
| March 29, 2021 |
Ex. 4.3 DESCRIPTION OF THE REGISTRANT?S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 Seer, Inc. (the ?Company?) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: our Class A common stock, par value $0.00001 per share. As used in this summary, the terms ?Seer,? ?the Company,? ?we,? ?our? and ?us? refer |
|
| February 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 13, 2021 Seer, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer incorpor |
|
| February 17, 2021 |
Ex. 99.1 Seer Appoints Deep Nishar and Mostafa Ronaghi, Ph.D. to its Board of Directors Company adds two directors with experience in building and growing transformative companies Redwood City, CA, February 17, 2021 — Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it has appointed Deep Nishar and Mostafa Ronaghi, Ph.D. |
|
| February 16, 2021 |
Exhibit 1 EXHIBIT 1 JOINT FILING AGREEMENT The undersigned agree that the statement on Schedule 13G with respect to the Class A Common Stock, par value $0. |
|
| February 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. )* SEER, INC. (Name of Issuer) Class A Common Stock, $0.00001 par value per share (Title of Class of Securities) 81578P 106 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the ru |
|
| February 16, 2021 |
SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934* (Amendment No. 1) SEER, INC. (Name of Issuer) Class A Common Stock, par value $0.00001 per share (Title of Class of Securities) 81578P106 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designa |
|
| February 8, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Seer, Inc. (Name of Issuer) Class A Common Stock, Par Value $0.001 per Share (Title of Class of Securities) 81578P106 (CUSIP Number) December 31, 2020 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which |
|
| January 29, 2021 |
As filed with the Securities and Exchange Commission on January 29, 2021 Registration No. |
|
| January 29, 2021 |
3,750,000 Shares Class A Common Stock Filed pursuant to Rule 424(b)(4) Registration Nos. 333-252395 and 333-252491 PROSPECTUS 3,750,000 Shares Class A Common Stock We are offering 1,650,000 shares of our Class A common stock. The selling stockholders identified in this prospectus, including our chief executive officer, are offering 2,100,000 shares of our Class A common stock. We will not receive any proceeds from the sale of shares o |
|
| January 27, 2021 |
As filed with the Securities and Exchange Commission on January 27, 2021. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SEER, INC. (Exact name of Registrant as specified in its charter) Delaware 3826 82-1153150 (State or other jurisdiction of incorporation or organization) (Primary Stan |
|
| January 25, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 25, 2021 SEER, INC. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of incorporation) (Commission File Number |
|
| January 25, 2021 |
List of subsidiaries of Registrant Exhibit 21.1 List of Subsidiaries: 1.Seer Securities Corporation (Massachusetts) |
|
| January 25, 2021 |
As filed with the Securities and Exchange Commission on January 25, 2021. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT Under The Securities Act of 1933 SEER, INC. (Exact name of Registrant as specified in its charter) Delaware 3826 82-1153150 (State or other jurisdiction of incorporation or organization) (Primary Stan |
|
| January 25, 2021 |
Seer Announces Proposed Public Offering of Common Stock Exhibit 99.1 Seer Announces Proposed Public Offering of Common Stock Redwood City, Calif. (January 25, 2021) – Seer, Inc., a life sciences company commercializing a disruptive new platform for proteomics, today announced the commencement of a proposed underwritten public offering of 3,500,000 shares of Class A common stock (1,400,000 of which are being offered for sale by Seer and 2,100,000 are be |
|
| January 25, 2021 |
Exhibit 4.2 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of December 9, 2020, by and among Seer, Inc., a Delaware corporation (the “Company”), each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor,” and each of the stockholders listed on Schedule B he |
|
| January 25, 2021 |
January 25, 2021 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, DC 20549-3720 Attention: Jason L. Drory Re: Seer, Inc. Registration Statement on Form S-1 (File No. 333-252395) Acceleration Request Requested Date: January 27, 2021 Requested Time: 4:00 P.M. Eastern Time Ladies and Gentlemen: Pursuant to Rule 46 |
|
| January 25, 2021 |
Form of Underwriting Agreement. Exhibit 1.1 SEER, INC. [●] Shares of Class A Common Stock, par value $0.00001 Underwriting Agreement [●], 2021 J.P. Morgan Securities LLC Morgan Stanley & Co. LLC BofA Securities, Inc. As Representatives of the several Underwriters listed in Schedule 1 hereto c/o J.P. Morgan Securities LLC 383 Madison Avenue New York, New York 10179 c/o Morgan Stanley & Co. LLC 1585 Broadway New York, New York 100 |
|
| January 25, 2021 |
CORRESP 1 filename1.htm J.P. Morgan Securities LLC 383 Madison Avenue New York, New York 10179 Morgan Stanley & Co. LLC 1585 Broadway New York, New York 10036 BofA Securities, Inc. One Bryant Park New York, New York 10036 United States Securities and Exchange Commission Division of Corporate Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Jason Drory Re: Seer, Inc. Registration Statem |
|
| January 15, 2021 |
As confidentially submitted to the Securities and Exchange Commission on January 15, 2021. |
|
| January 15, 2021 |
EX-21.1 3 filename3.htm Exhibit 21.1 List of Subsidiaries: 1.Seer Securities Corporation (Massachusetts) |
|
| January 15, 2021 |
AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT Exhibit 4.2 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of December 9, 2020, by and among Seer, Inc., a Delaware corporation (the “Company”), each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor,” and each of the stockholders listed on Schedule B he |
|
| January 11, 2021 |
EX-99.3 4 d31009dex993.htm EXHIBIT 3 Exhibit 3 Power of Attorney KNOW ALL MEN BY THESE PRESENTS, that I, Andrew H. Warford, hereby make, constitute and appoint Mark Gurevich as my agent and attorney-in-fact for the purpose of executing (i) in my personal capacity or (ii) in my capacity as manager or other officer or representative of Maverick Capital, Ltd. or any affiliate of either, all documents |
|
| January 11, 2021 |
Exhibit 4 Exhibit 4 Power of Attorney KNOW ALL MEN BY THESE PRESENTS, that I, David B. |
|
| January 11, 2021 |
SC 13D SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment )* Seer, Inc. (Name of Issuer) Class A Common Stock (Title of Class of Securities) 81578P 106 (CUSIP Number) Mark Gurevich Maverick Capital, Ltd. 1900 N. Pearl Street, 20th Floor Dallas, TX 75201 (214) 880-4000 (Name, Address and Telephone Number of Person Authorized t |
|
| January 11, 2021 |
Exhibit 1 Exhibit 1 JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13D with respect to the Class A common stock, par value $0. |
|
| January 11, 2021 |
Exhibit 2 Exhibit 2 Power of Attorney KNOW ALL MEN BY THESE PRESENTS, that I, Lee S. |
|
| January 4, 2021 |
EX-B Exhibit B Power of Attorney KNOW ALL MEN BY THESE PRESENTS, that I, Lee S. Ainslie III, hereby make, constitute and appoint Mark Gurevich as my agent and attorney-in -fact for the purpose of executing (i) in my personal capacity or (ii) in my capacity as manager or other officer or representative of Maverick Capital Management, LLC, Maverick Capital, Ltd. or any affiliate of either, all docum |
|
| January 4, 2021 |
EX-A EXHIBIT A JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13G with respect to the Class A common stock, par value $0. |
|
| January 4, 2021 |
SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Seer, Inc. (Name of Issuer) Class A Common Stock (Title of Class of Securities) 81578P 106 (CUSIP Number) December 8, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which thi |
|
| December 18, 2020 |
SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934* (Amendment No. ) SEER, INC. (Name of Issuer) Class A Common Stock, par value $0.00001 per share (Title of Class of Securities) 81578P106 (CUSIP Number) December 8, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate t |
|
| December 18, 2020 |
EX-99.1 EXHIBIT 1 JOINT FILING AGREEMENT The undersigned agree that the statement on Schedule 13G with respect to the Class A Common Stock, par value $0.00001 per share, of Seer, Inc., dated as of December 18, 2020, is, and any amendments thereto signed by each of the undersigned shall be, filed on behalf of each of them pursuant to and in accordance with the provisions of Rule 13d-1(k) under the |
|
| December 18, 2020 |
EX-99 Exhibit 99 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that they are jointly filing this statement on Schedule 13G. |
|
| December 18, 2020 |
SC 13G 1 d22322dsc13g.htm SC 13G United States Securities and Exchange Commission Washington, D.C. 20549 Schedule 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to § 240.13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.)* Seer, Inc. (Name of Issuer) Class A Common Stock (Title of Class of |
|
| December 8, 2020 |
Amended and Restated Certificate of Incorporation of the Registrant Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF SEER, INC. Seer, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), does hereby certify as follows: A.The name of the Corporation is Seer, Inc. The Corporation was originally incorporated pursuant to the General Corporation Law of the State of Delaware (“DGCL”) on March 16, 2017 un |
|
| December 8, 2020 |
Exhibit 99.1 Seer Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares Redwood City, Calif. (December 8, 2020) – Seer, Inc., a life sciences company focused on enabling exceptional scientific outcomes through the power of unbiased, deep, rapid and scalable proteomics information, today announced the closing of its initial public offer |
|
| December 8, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 8, 2020 SEER, INC. (Exact name of registrant as specified in its charter) Delaware 001-39747 82-1153150 (State or other jurisdiction of incorporation) (Commission File Number |
|
| December 8, 2020 |
Amended and Restated Bylaws of the Registrant. Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF SEER, INC. (initially adopted on November 18, 2020) (as amended on December 8, 2020 and effective as of the closing of the corporation’s initial public offering) TABLE OF CONTENTS Page ARTICLE I - CORPORATE OFFICES 1 1.1 REGISTERED OFFICE 1 1.2 OTHER OFFICES 1 ARTICLE II - MEETINGS OF STOCKHOLDERS 1 2.1 PLACE OF MEETINGS 1 2.2 ANNUAL MEETING 1 2.3 SPECIAL |
|
| December 4, 2020 |
As filed with the Securities and Exchange Commission on December 3, 2020. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SEER, INC. (Exact name of Registrant as specified in its charter) Delaware 3826 82-1153150 (State or other jurisdiction of incorporation or organization) (Primary Stan |
|
| December 4, 2020 |
As filed with the Securities and Exchange Commission on December 4, 2020 Registration No. |
|
| December 4, 2020 |
9,210,527 Shares Class A Common Stock Filed pursuant to Rule 424(b)(4) Registration Nos. 333-250035 and 333-251116 PROSPECTUS 9,210,527 Shares Class A Common Stock We are offering 9,210,527 shares of our Class A common stock. This is our initial public offering of our Class A common stock, and no public market currently exists for our Class A common stock. The rights of the holders of Class A common stock and Class B common stock are |
|
| December 1, 2020 |
December 1, 2020 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, DC 20549-3720 Attention: Al Pavot Tracie Mariner Celeste Murphy Chris Edwards Re: Seer, Inc. Registration Statement on Form S-1 (File No. 333-250035) Acceleration Request Requested Date: December 3, 2020 Requested Time: 4:00 P.M. Eastern Time Lad |
|
| December 1, 2020 |
J.P. Morgan Securities LLC 383 Madison Avenue New York, New York 10179 Morgan Stanley & Co. LLC 1585 Broadway New York, New York 10036 BofA Securities, Inc. One Bryant Park New York, New York 10036 December 1, 2020 VIA EMAIL AND EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 RE: Seer, Inc. Registration Statement on Form S-1 F |
|
| November 30, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 SEER, INC. (Exact name of Registrant as specified in its charter) Delaware 82-1153150 (State of incorporation or organization) (I.R.S. Employer Identification No.) 3800 Bridge Parkway, Suite 102 Re |
|
| November 30, 2020 |
Exhibit 10.10 SEER, INC. CEO CHANGE IN CONTROL AND SEVERANCE AGREEMENT This CEO Change in Control and Severance Agreement (the “Agreement”) is made by and between Seer, Inc., a Delaware corporation, and Omid Farokhzad (“Executive”), effective as of the day immediately prior to the Registration Date, as defined below (the “Effective Date”). This Agreement provides certain protections to Executive i |
|
| November 30, 2020 |
Confirmatory Offer Letter between the Registrant and Dr. Omid Farokhzad, dated November 30, 2020. Exhibit 10.7 November 30, 2020 Omid Farokhzad Via email Re: Confirmatory Employment Letter Dear Omid: This confirmatory employment letter agreement (the “Agreement”) is entered into between Omid Farokhzad (“you”) and Seer, Inc. (the “Company” or “we”), effective as of the day immediately prior to the Registration Date (the “Effective Date”), to confirm the terms and conditions of your employment w |
|
| November 30, 2020 |
2020 RSU Equity Incentive Plan and related form agreements. Exhibit 10.4 SEER, INC. 2020 RSU EQUITY INCENTIVE PLAN (As amended and restated November 18, 2020) 1.Purposes of the Plan. The purposes of this Plan are: •to attract and retain the best available personnel for positions of substantial responsibility, •to provide additional incentive to Employees, Directors and Consultants, and •to promote the success of the Company’s business. The Plan permits the |
|
| November 30, 2020 |
2017 Stock Incentive Plan and related form agreements. Exhibit 10.3 SEER, INC. 2017 Stock Incentive Plan (As Amended and Restated November 18, 2020) 1.Purpose. The purpose of this plan (the “Plan”) is to secure for Seer, Inc., a Delaware corporation, or any successor thereto (the “Company”) and its shareholders the benefits arising from capital stock ownership by employees, officers and directors of, and consultants or advisors to, the Company and its |
|
| November 30, 2020 |
2020 Employee Stock Purchase Plan. Exhibit 10.5 SEER, INC. 2020 EMPLOYEE STOCK PURCHASE PLAN 1.Purpose. The purpose of the Plan is to provide employees of the Company and its Designated Companies with an opportunity to purchase Common Stock through accumulated Contributions. The Company intends for the Plan to have two components: a component that is intended to qualify as an “employee stock purchase plan” under Code Section 423 (t |
|
| November 30, 2020 |
Confirmatory Offer Letter between the Registrant and Omead Ostadan, dated November 30, 2020. Exhibit 10.8 November 30, 2020 Omead Ostadan Via email Re: Confirmatory Employment Letter Dear Omead: This confirmatory employment letter agreement (the “Agreement”) is entered into between Omead Ostadan (“you”) and Seer, Inc. (the “Company” or “we”), effective as of the day immediately prior to the Registration Date (the “Effective Date”), to confirm the terms and conditions of your employment wi |
|
| November 30, 2020 |
Confirmatory Offer Letter between the Registrant and David Horn, dated November 30, 2020. Exhibit 10.9 November 30, 2020 David Horn Via email Re: Confirmatory Employment Letter Dear David: This confirmatory employment letter agreement (the “Agreement”) is entered into between David Horn (“you”) and Seer, Inc. (the “Company” or “we”), effective as of the day immediately prior to the Registration Date (the “Effective Date”), to confirm the terms and conditions of your employment with the |
|
| November 30, 2020 |
2020 Equity Incentive Plan and related form agreements. Exhibit 10.2 SEER, INC. 2020 EQUITY INCENTIVE PLAN 1.Purposes of the Plan. The purposes of this Plan are: •to attract and retain the best available personnel for positions of substantial responsibility, •to provide additional incentive to Employees, Directors and Consultants, and •to promote the success of the Company’s business. The Plan permits the grant of Incentive Stock Options, Nonstatutory |
|
| November 30, 2020 |
Executive Incentive Compensation Plan Exhibit 10.11 SEER, INC. EXECUTIVE INCENTIVE COMPENSATION PLAN 1.Purposes of the Plan. The Plan is intended to increase stockholder value and the success of the Company by motivating Employees to (a) perform to the best of their abilities and (b) achieve the Company’s objectives. 2.Definitions. 2.1“Actual Award” means as to any Performance Period, the actual award (if any) payable to a Participant |
|
| November 30, 2020 |
Form of Underwriting Agreement. Exhibit 1.1 SEER, INC. [l] Shares of Class A Common Stock, par value $0.00001 Underwriting Agreement [l], 2020 J.P. Morgan Securities LLC Morgan Stanley & Co. LLC BofA Securities, Inc. As Representatives of the several Underwriters listed in Schedule 1 hereto c/o J.P. Morgan Securities LLC 383 Madison Avenue New York, New York 10179 c/o Morgan Stanley & Co. LLC 1585 Broadway New York, New York 100 |
|
| November 30, 2020 |
Exhibit 3.2 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF SEER, INC. Seer, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), does hereby certify as follows: A.The name of the Corporation is Seer, Inc. The Corporation was originally incorporated pursuant to the General Corporation Law of the State of Delaware (“DGCL”) on March 16, 2017 un |
|
| November 30, 2020 |
Outside Director Compensation Policy. Exhibit 10.12 SEER, INC. OUTSIDE DIRECTOR COMPENSATION POLICY Seer, Inc. (the “Company”) believes that the granting of equity and cash compensation to members of the Company’s Board of Directors (the “Board,” and members of the Board, “Directors”) represents an effective tool to attract, retain and reward Directors who are not employees of the Company (“Outside Directors”). This Outside Director C |
|
| November 30, 2020 |
As filed with the Securities and Exchange Commission on November 30, 2020 Registration No. |
|
| November 30, 2020 |
Amended and Restated Certificate of Incorporation of the Registrant Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF SEER, INC. (Pursuant to Sections 242 and 245 of the General Corporation Law of the State of Delaware) Seer, Inc., a corporation organized and existing under and by virtue of the provisions of the General Corporation Law of the State of Delaware (the “General Corporation Law”), DOES HEREBY CERTIFY: 1.That the name of this corporation |
|
| November 30, 2020 |
Key Executive Change in Control and Severance Plan, and form of Participation Agreement thereunder. Exhibit 10.6 SEER, INC. KEY EXECUTIVE CHANGE IN CONTROL AND SEVERANCE PLAN 1.Introduction. This Seer, Inc. Key Executive Change in Control and Severance Plan (as may be amended from time to time, this “Plan”) has been adopted by Seer, Inc. (the “Company”), effective as of the day immediately prior to the Registration Date (the “Effective Date”), in order to provide specified severance pay and bene |
|
| November 12, 2020 |
650 Page Mill Road Palo Alto, CA 94304-1050 PHONE 650.493.9300 FAX 650.493.6811 www.wsgr.com November 12, 2020 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549-3720 Attention: Al Pavot Tracie Mariner Celeste Murphy Chris Edwards Re: Seer, Inc. Amendment No. 1 to Draft Registration Statement on Form S |
|
| November 12, 2020 |
As filed with the Securities and Exchange Commission on November 12, 2020 Registration No. |
|
| November 12, 2020 |
Exhibit 10.1 SEER, INC. INDEMNIFICATION AGREEMENT This Indemnification Agreement (this ?Agreement?) is dated as of [, 2020] and is between Seer, Inc., a Delaware corporation (the ?Company?), and [insert name of indemnitee] (?Indemnitee?). RECITALS A. Indemnitee?s service to the Company substantially benefits the Company. B. Individuals are reluctant to serve as directors or officers of corporation |
|
| November 12, 2020 |
2017 Equity Incentive Plan and related form agreements. Exhibit 10.3 SEER BIOSCIENCES, INC. 2017 Stock Incentive Plan 1.Purpose. The purpose of this plan (the ?Plan?) is to secure for Seer Biosciences, Inc., a Delaware corporation (the ?Company?) and its shareholders the benefits arising from capital stock ownership by employees, officers and directors of, and consultants or advisors to, the Company and its parent and subsidiary corporations who are ex |
|
| November 12, 2020 |
Form of common stock certificate of the Registrant. Exhibit 4.1 |
|
| November 12, 2020 |
Exhibit 10.14 EXECUTION [***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed. Umbrella Development & Supply Agreement between Seer, Inc and Hamilton Company Page 1 of 30 Table of Contents ARTICLE 1 ? DEFINITIONS 4 ARTICLE 2 ? |
|
| November 12, 2020 |
Exhibit 10.16 SEER, INC. CLASS A COMMON STOCK PURCHASE AGREEMENT November 12, 2020 TABLE OF CONTENTS Page 1. Purchase and Sale of Stock 1 1.1 Sale and Issuance of Class A Common Stock 1 1.2 Closing 1 2. Registration Rights 1 3. Representations and Warranties of the Company 2 3.1 Organization, Good Standing and Qualification 2 3.2 Corporate Power; Authorization 2 3.3 Valid Issuance of Class A Commo |
|
| November 12, 2020 |
Exhibit 3.4 AMENDED AND RESTATED BYLAWS OF SEER, INC. (initially adopted on [], 2020) (as amended on [], 2020 and effective as of the closing of the corporation?s initial public offering) TABLE OF CONTENTS Page ARTICLE I - CORPORATE OFFICES 1 1.1 REGISTERED OFFICE 1 1.2 OTHER OFFICES 1 ARTICLE II - MEETINGS OF STOCKHOLDERS 1 2.1 PLACE OF MEETINGS 1 2.2 ANNUAL MEETING 1 2.3 SPECIAL MEETING 1 2.4 AD |
|
| November 12, 2020 |
Exhibit 10.15 [***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed. THE BRIGHAM AND WOMEN?S HOSPITAL, INC. EXCLUSIVE PATENT LICENSE AGREEMENT BWH Agreement No: [***] BWH Cases Nos: [***], [***], [***] and [***] This License A |
|
| November 12, 2020 |
2020 RSU Equity Incentive Plan and related form agreements. Exhibit 10.4 SEER, INC. 2020 RSU EQUITY INCENTIVE PLAN (As amended and restated July 28, 2020) 1.Purposes of the Plan. The purposes of this Plan are: ?to attract and retain the best available personnel for positions of substantial responsibility, ?to provide additional incentive to Employees, Directors and Consultants, and ?to promote the success of the Company?s business. The Plan permits the gra |
|
| November 12, 2020 |
Exhibit 3.2 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF SEER, INC. Seer, Inc., a corporation organized and existing under the laws of the State of Delaware (the ?Corporation?), does hereby certify as follows: A.The name of the Corporation is Seer, Inc. The Corporation was originally incorporated pursuant to the General Corporation Law of the State of Delaware (?DGCL?) on March 16, 2017 un |
|
| November 12, 2020 |
Exhibit 4.2 AMENDED AND RESTATED INVESTORS? RIGHTS AGREEMENT THIS AMENDED AND RESTATED INVESTORS? RIGHTS AGREEMENT (this ?Agreement?), is made as of the 12th day of May, 2020, by and among Seer, Inc., a Delaware corporation (the ?Company?), each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an ?Investor,? and each of the stockholders listed on Sche |
|
| November 12, 2020 |
Exhibit 4.3 AMENDED AND RESTATED INVESTORS? RIGHTS AGREEMENT THIS AMENDED AND RESTATED INVESTORS? RIGHTS AGREEMENT (this ?Agreement?), is made as of , 2020, by and among Seer, Inc., a Delaware corporation (the ?Company?), each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an ?Investor,? and each of the stockholders listed on Schedule B hereto, each |
|
| November 12, 2020 |
Amended and Restated Certificate of Incorporation of the Registrant, as currently in effect. Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF SEER, INC. (Pursuant to Sections 242 and 245 of the General Corporation Law of the State of Delaware) Seer, Inc., a corporation organized and existing under and by virtue of the provisions of the General Corporation Law of the State of Delaware (the ?General Corporation Law?), DOES HEREBY CERTIFY: 1.That the name of this corporation |
|
| November 12, 2020 |
Amended and Restated Bylaws of the Registrant, as amended, as currently in effect. Exhibit 3.3 Adopted March 16, 2017 BY-LAWS OF SEER BIOSCIENCES, INC. Section 1CERTIFICATE OF INCORPORATION AND BY-LAWS 1.1These by-laws are subject to the certificate of incorporation of the corporation. In these by-laws, references to the certificate of incorporation and by-laws mean the provisions of the certificate of incorporation and the by-laws as are from time to time in effect. Section 2OF |
|
| October 30, 2020 |
650 Page Mill Road Palo Alto, CA 94304-1050 650.493.9300 650.493.6811 www.wsgr.com October 30, 2020 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549-3720 Attention: Al Pavot Tracie Mariner Celeste Murphy Chris Edwards Re: Seer, Inc. Draft Registration Statement on Form S-1 Confidentially Submitted Se |
|
| October 30, 2020 |
SEER, INC. INDEMNIFICATION AGREEMENT EX-10.1 2 filename2.htm Exhibit 10.1 DRAFT SEER, INC. INDEMNIFICATION AGREEMENT This Indemnification Agreement (this “Agreement”) is dated as of [, 2020] and is between Seer, Inc., a Delaware corporation (the “Company”), and [insert name of indemnitee] (“Indemnitee”). RECITALS A. Indemnitee’s service to the Company substantially benefits the Company. B. Individuals are reluctant to serve as direct |
|
| October 30, 2020 |
Amendment No. 1 to Draft Registration Statement, as confidentially submitted to the Securities and Exchange Commission on October 30, 2020. This draft registration statement has not been publicly filed with the Securities and Exchange Commission and all information herein remains strictly confidential. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FO |
|
| October 30, 2020 |
Exhibit 10.15 [***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed. THE BRIGHAM AND WOMEN?S HOSPITAL, INC. EXCLUSIVE PATENT LICENSE AGREEMENT BWH Agreement No: [***] BWH Cases Nos: [***], [***], [***] and [***] This License A |
|
| September 25, 2020 |
DRS 1 filename1.htm As confidentially submitted to the Securities and Exchange Commission on September 25, 2020. This draft registration statement has not been publicly filed with the Securities and Exchange Commission and all information herein remains strictly confidential. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEME |
|
| September 25, 2020 |
EX-3.1 2 filename2.htm Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF SEER, INC. (Pursuant to Sections 242 and 245 of the General Corporation Law of the State of Delaware) Seer, Inc., a corporation organized and existing under and by virtue of the provisions of the General Corporation Law of the State of Delaware (the “General Corporation Law”), DOES HEREBY CERTIFY: 1.That the na |
|
| September 25, 2020 |
BY-LAWS SEER BIOSCIENCES, INC. Exhibit 3.3 Adopted March 16, 2017 BY-LAWS OF SEER BIOSCIENCES, INC. Section 1CERTIFICATE OF INCORPORATION AND BY-LAWS 1.1These by-laws are subject to the certificate of incorporation of the corporation. In these by-laws, references to the certificate of incorporation and by-laws mean the provisions of the certificate of incorporation and the by-laws as are from time to time in effect. Section 2OF |
|
| September 25, 2020 |
AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT Exhibit 4.2 AMENDED AND RESTATED INVESTORS? RIGHTS AGREEMENT THIS AMENDED AND RESTATED INVESTORS? RIGHTS AGREEMENT (this ?Agreement?), is made as of the 12th day of May, 2020, by and among Seer, Inc., a Delaware corporation (the ?Company?), each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an ?Investor,? and each of the stockholders listed on Sche |
|
| September 25, 2020 |
Umbrella Development & Supply Agreement Seer, Inc Hamilton Company Exhibit 10.6 EXECUTION [***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed. Umbrella Development & Supply Agreement between Seer, Inc and Hamilton Company Page 1 of 30 Table of Contents ARTICLE 1 ? DEFINITIONS 4 ARTICLE 2 ? |
|
| September 25, 2020 |
SEER BIOSCIENCES, INC. 2017 Stock Incentive Plan EX-10.3 5 filename5.htm Exhibit 10.3 SEER BIOSCIENCES, INC. 2017 Stock Incentive Plan 1.Purpose. The purpose of this plan (the “Plan”) is to secure for Seer Biosciences, Inc., a Delaware corporation (the “Company”) and its shareholders the benefits arising from capital stock ownership by employees, officers and directors of, and consultants or advisors to, the Company and its parent and subsidiary |
|
| September 25, 2020 |
SEER, INC. 2020 RSU EQUITY INCENTIVE PLAN (As amended and restated July 28, 2020) Exhibit 10.4 SEER, INC. 2020 RSU EQUITY INCENTIVE PLAN (As amended and restated July 28, 2020) 1.Purposes of the Plan. The purposes of this Plan are: ?to attract and retain the best available personnel for positions of substantial responsibility, ?to provide additional incentive to Employees, Directors and Consultants, and ?to promote the success of the Company?s business. The Plan permits the gra |
